![Atomwise Signs Strategic Multi-Target Research Collaboration with Sanofi for AI-Powered Drug Discovery – Atomwise Atomwise Signs Strategic Multi-Target Research Collaboration with Sanofi for AI-Powered Drug Discovery – Atomwise](https://www.atomwise.com/wp-content/uploads/2022/08/atomwise-signs-strategic-collaboration-sanofi-pr-1200x630-1.png)
Atomwise Signs Strategic Multi-Target Research Collaboration with Sanofi for AI-Powered Drug Discovery – Atomwise
Press Release: Sanofi unveils new corporate brand and logo – unites the company under one purpose and a single identity
![Logo of Pharmaceutical French group Sanofi-Aventis during a press conference to present the full-year 2005 results. Sanofi-Aventis announced a serie of positive drug research developments, in Paris, on February 24, 2006. Photo Logo of Pharmaceutical French group Sanofi-Aventis during a press conference to present the full-year 2005 results. Sanofi-Aventis announced a serie of positive drug research developments, in Paris, on February 24, 2006. Photo](https://c8.alamy.com/comp/2E95XFE/logo-of-pharmaceutical-french-group-sanofi-aventis-during-a-press-conference-to-present-the-full-year-2005-results-sanofi-aventis-announced-a-serie-of-positive-drug-research-developments-in-paris-on-february-24-2006-photo-by-christophe-guibbaudabacapresscom-2E95XFE.jpg)
Logo of Pharmaceutical French group Sanofi-Aventis during a press conference to present the full-year 2005 results. Sanofi-Aventis announced a serie of positive drug research developments, in Paris, on February 24, 2006. Photo
![Flatiron Health Embarks on Strategic Collaboration with Sanofi to Make Clinical Trials More Efficient by Streamlining Data Acquisition at the Point of Care | BioSpace Flatiron Health Embarks on Strategic Collaboration with Sanofi to Make Clinical Trials More Efficient by Streamlining Data Acquisition at the Point of Care | BioSpace](https://mms.businesswire.com/media/20230501005091/en/1778081/4/Press-Featured-Image-SanofixFlatiron.jpg)
Flatiron Health Embarks on Strategic Collaboration with Sanofi to Make Clinical Trials More Efficient by Streamlining Data Acquisition at the Point of Care | BioSpace
![PRESS RELEASE: Sanofi Partnering With Leading Academic Cooperative Groups To Study Amcenestrant In The Adjuvant Setting For Patients With Estrogen Receptor Positive Breast Cancer 2023 - EORTC PRESS RELEASE: Sanofi Partnering With Leading Academic Cooperative Groups To Study Amcenestrant In The Adjuvant Setting For Patients With Estrogen Receptor Positive Breast Cancer 2023 - EORTC](http://www.eortc.org/app/uploads/2021/06/Sanofi_press-release.jpg)
PRESS RELEASE: Sanofi Partnering With Leading Academic Cooperative Groups To Study Amcenestrant In The Adjuvant Setting For Patients With Estrogen Receptor Positive Breast Cancer 2023 - EORTC
Nancy Whiting on LinkedIn: Recludix Pharma Enters into a Strategic Collaboration with Sanofi to… | 20 comments
![Scribe Therapeutics Expands Collaboration with Sanofi to Advance In Vivo Genetic Medicines for Sickle Cell and Other Genomic Diseases | Business Wire Scribe Therapeutics Expands Collaboration with Sanofi to Advance In Vivo Genetic Medicines for Sickle Cell and Other Genomic Diseases | Business Wire](https://mms.businesswire.com/media/20230717825654/en/1633762/23/Scribe_Logo.jpg)
Scribe Therapeutics Expands Collaboration with Sanofi to Advance In Vivo Genetic Medicines for Sickle Cell and Other Genomic Diseases | Business Wire
![Sanofi on Twitter: "We're pleased to announce the acquisition of Origimm, an Austrian #biotechnology company specializing in the discovery of virulent skin microbiome components and antigens from bacteria causing #skindiseases, such as # Sanofi on Twitter: "We're pleased to announce the acquisition of Origimm, an Austrian #biotechnology company specializing in the discovery of virulent skin microbiome components and antigens from bacteria causing #skindiseases, such as #](https://pbs.twimg.com/media/FFgEnuYX0AMAFyN.png:large)
Sanofi on Twitter: "We're pleased to announce the acquisition of Origimm, an Austrian #biotechnology company specializing in the discovery of virulent skin microbiome components and antigens from bacteria causing #skindiseases, such as #
![Sanofi в X: „Press release: #Sanofi announces that it will acquire @ProteinSciences https://t.co/Uvipij6Bkr https://t.co/FoBXWy5xe4“ / X Sanofi в X: „Press release: #Sanofi announces that it will acquire @ProteinSciences https://t.co/Uvipij6Bkr https://t.co/FoBXWy5xe4“ / X](https://pbs.twimg.com/media/DEhiniWXcAIbYeM.jpg)
Sanofi в X: „Press release: #Sanofi announces that it will acquire @ProteinSciences https://t.co/Uvipij6Bkr https://t.co/FoBXWy5xe4“ / X
Sanofi on X: "#SanofiActs against #COVID19 Read more on our latest collaboration with @TranslateBio, investigating multiple candidates, with the goal of advancing an efficacious and safe SARS-CoV-2 vaccine into clinical development. https://t.co/C8B5bsy7DH
PDF - Paris2024-Press Release - Sanofi announces Paris 2024 Premium partnership for the Olympic and Paralympic Games in Paris.pdf
![SK bioscience-Sanofi Announce Positive Results from Phase II Study of 21-Valent Pneumococcal Conjugate Vaccine Candidate SK bioscience-Sanofi Announce Positive Results from Phase II Study of 21-Valent Pneumococcal Conjugate Vaccine Candidate](https://mma.prnewswire.com/media/2144614/Jaeyong_Ahn_CEO_of_SK_bioscience__left__Thomas_Triomphe_Head_of_Vaccines_GBU_at_Sanofi__right.jpg?p=facebook)